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Abstract
Nuclear transfer (NT) is a procedure by which genetically identical individuals can be created. The
technology of pig somatic NT, including in vitro maturation of oocytes, isolation and treatment of
donor cells, artificial activation of reconstructed oocytes, embryo culture and embryo transfer, has
been intensively studied in recent years, resulting in birth of cloned pigs in many labs. While it
provides an efficient method for producing transgenic pigs, more importantly, it is the only way to
produce gene-targeted pigs. So far pig cloning has been successfully used to produce transgenic pigs
expressing the green fluorescence protein, expand transgenic pig groups and create gene targeted
pigs which are deficient of alpha-1,3-galactosyltransferase. The production of pigs with genetic
modification by NT is now in the transition from investigation to practical use. Although the
efficiency of somatic cell NT in pig, when measured as development to term as a proportion of
oocytes used, is not high, it is anticipated that the ability of making specific modifications to the
swine genome will result in this technology having a large impact not only on medicine but also on
agriculture.
Introduction
Pronuclear DNA micro-injection has long been the most
reliable method to produce transgenic pigs. Despite the
ease with which transgenic pigs can be generated this tech-
nique has limitations. The DNA integrates randomly and
potentially in multiple copies. In addition, the random
site of integration limits the ability to control expression
in the desired tissues or at the appropriate level. Moreover,
the animal's endogenous genes cannot be specifically
altered by using this technique.
Successful nuclear transfer (NT) of cultured cells, which
was first demonstrated in cattle [1], has provided an alter-
native for obtaining genetically modified pigs. McCreath
et al. [2] reported the first success of obtaining gene-target-
ing sheep by using gene-targeted fibroblasts as a source of
donor nuclei for NT. Although NT of pigs once lagged
behind that in mice, cattle and sheep, since the first piglet
from somatic cell NT was reported in 2000 [3], tremen-
dous progress has been made. Successful production of
pigs resulting from random genetic modification in vitro
followed by NT [4–6], as well as those with a specific
modification (knock out) have been reported [7–10] by
several groups in a short period. The production of cloned
transgenic pigs is now in the transition from investigation
to practical application. In this paper, we discuss the
present status of production efficiency of transgenic pigs
by NT; as well as the problems and offer a few perspec-
tives.
History of pig cloning
The first successful cloning experiment in pigs was
reported as early as in 1989. Prather et al., [11] used blas-
tomeres from 4-cell stage embryos as donor nuclei and in
vivo-derived metaphase II oocytes as recipient cytoblasts.
A total of 88 NT embryos were transferred to recipient gilts
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for continued development. A single piglet was born. Sim-
ilar success was not reported with embryonic cells until
more than 10 years later [12]. With a similar NT technique
that produced Dolly – in which a cultured differentiated
somatic cell is fused with a mature egg whose genetic
material has been removed [13], successful cloning of pigs
was not reported until 3 years later [3,14]. Pigs are physi-
ologically similar to humans and so there has been
intense interest in using genetically modified pigs as organ
donors for transplantation to humans, as well as models
of human disease.
In 2000, the first somatic cell cloning success was Pole-
jaeva et al. [3] who announced the birth of five healthy
cloned piglets. These animals were produced via a differ-
ent technology from that generally used for NT. The
authors first fused porcine granulosa-derived donor cells
to enucleated mature oocytes. After 18 hours, the donor
nucleus was removed from the first oocyte and transferred
to the cytoplasm of a fertilized egg. The investigators
adopted this double NT strategy because they surmised
that in the original one-step method, the activation stim-
ulus provided after NT was insufficient to support full-
term development of the embryo. This report lead the pig
cloners to think that the procedures of pig cloning might
be more complicated and difficult than other animals.
However, almost at the same time, Onishi et al. [14]
reported the birth of a live cloned piglet, by directly inject-
ing porcine fetal fibroblast donor nuclei into enucleated
oocytes with piezo-actuated microinjection. The signifi-
cance of Onishi's success is that they proved that two-step
NT is unnecessary to make somatic NT pig. Both groups
used mature oocytes collected directly from female pigs
rather than culturing immature oocytes in vitro. Matured
oocytes are needed in large numbers and in vivo matured
oocytes are very expensive to acquire. Thus many have
chosen to use in vitro matured oocytes. Immature oocytes
are derived from ovaries obtained from the slaughter-
house and subsequently matured in vitro. Betthauser et al.
[15] had systematically optimized each step in the NT pro-
cedure, including the source of oocytes and their matura-
tion in vitro, the culture of donor cells, the activation of
oocytes following NT, and the in vitro culture of embryos
and their transfer to recipient gilts. The result is a more
reproducible methodology that enables strategies to
genetically modify pigs.
Park et al. [4] reported the first pigs produced by geneti-
cally modifying the fibroblast cells prior to NT. This was
followed by Lai et al. [7] showing the first pigs with a gene
knocked out. Homologous recombination was used to
disrupt the sequence of the α-1, 3-galactosyltransferase
(GGTA1) gene in mini-pig fibroblasts. The targeted
fibroblast nuclei were transferred into enucleated in vitro
matured oocytes. Four live GGTA1 knockout pigs were
successfully produced. An important practical significance
of this experiment is to facilitate studies in xenotransplan-
tation of pig organs to humans, as elimination of terminal
α-1, 3-galactosyl epitopes from the pig is expected to be a
solution to the problem of hyperacute and delayed vascu-
lar rejection.
Unique aspects of pig cloning technology
The efficiency of somatic cell NT, when measured as
development to term as a proportion of oocytes used, has
been very low (1–2%). A number of variables influence
the ability to reproduce a specific genotype by cloning.
These include species, source of recipient ova, cell type of
nuclei donor, treatment of donor cells prior to NT, the
method of artificial oocyte activation, embryo culture,
possible loss of somatic imprinting in the nuclei of recon-
structed embryos, failure of reprogramming the trans-
planted nucleus adequately, and the techniques
employed for NT. In the pig, there is an additional diffi-
culty that at least 4 good embryos are required to induce
and maintain pregnancy. Therefore, to increase the chance
of producing offspring efforts to minimize the inefficien-
cies at each step of NT procedure must be made. Some of
the variables are discussed below.
Selection of cell types used to produce cloned pigs
In mice, at least eight types of fetal and adult origin from
males and females and different genetic backgrounds have
been tested. Live offspring were obtained with similar effi-
ciency only with fibroblast, undefined fetal gonad and
cumulus cells [16]. Many cell types (macrophages, spleen,
brain and mature Sertoli cells) repeatedly failed to
develop after implantation. In cattle, at least fifteen
somatic cell donors of fetal, newborn and adult origin
from males and female and different genetic backgrounds
were tested [17] and all supported development in vitro,
and live offspring were obtained from cumulus, oviduct,
skin and liver cells. Ten different somatic cell types have
proven complete cloning-competence so far. In pigs,
fibroblast and cumulus cells have been clonable. The use
of isolated precursor cells of adipocytes from the subcuta-
neous adipose tissue of adult pigs for NT [18] have also
has been documented.
Treatment of donor cells
The use of cultured cell populations for production of ani-
mals by NT is now well documented in a number of spe-
cies. Analysis of these cells has shown considerable
variation in development between individual cell popula-
tions and at present has provided no definitive method
for identification of cell populations that are best suited
for NT. Factors that are thought to influence the suitability
include the effects of oxidative damage associated with
metabolism, genome instability and chromosomal
pathologies. All of these factors may be influenced by theReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/82
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method of isolation and culture, and the number of pop-
ulation doublings in culture. Even different subclones of
fibroblasts derived from same fetus and cultured in same
conditions to same generation lead to different in vitro
developmental potential of reconstructed embryos [19].
Another factor affecting the efficiency of NT is the cell
cycle phase of donor cells, which is still a topic being
debated in the NT field. Wilmut et al. [13] stated that the
donor cells for NT must be in G0 of the cell cycle (quies-
cent phase), while Cibelli et al. [20] showed that cycling
cells, which contain cells in different cycle stages, could be
successfully used for NT in cattle. Cells in G2/M stage of
the cell cycle may be another option as these have been
used as nuclear donors to produce cloned mice [21], a pig
[6], and sheep [22].
Possible donor cells for genetic modification
Cells to be used as a source of donor nuclei for the produc-
tion of genetically modified pigs must meet two criteria:
1) they must be able to direct term development, and 2)
they should possess a proliferative ability such that correct
DNA modification can be selected. Fetal-derived fibrob-
lasts are a popular choice of cells to begin studies as they
are capable of extensive proliferation.
The problem with all somatic cells is that they tend to
become senescent before sufficient rounds of gene trans-
fer and/or targeting and selection can be performed. This
problem may be overcome by isolation of readily trans-
fectable and selectable cells with high proliferative poten-
tial and long-term karyotypical normalcy, similar to
murine ES and EG cell lines. Primordial germ cell-derived
lines have been isolated from pig fetuses, and transfected
lines have been shown to contribute to chimera formation
when injected into pig blastocysts [23,24], but in no case
has germ line transmission been demonstrated. Thus fur-
ther development is needed to create cells that are devel-
opmentally competent and able to proliferate indefinitely
in vitro.
Construction of nuclear transfer embryos
Oocytes must be enucleated for use in NT. One of the
common chemicals used to facilitate enucleation by per-
mitting visualization of the chromosomes is bisbenzim-
ide. Unfortunately, exposure to this compound has
deleterious effects on the development of pig oocytes to
the blastocyst stage. Since the condensed chromosomes
are always located in cytoplasm underneath the first polar
body, enucleation of in vitro matured metaphase II
oocytes can be performed by aspirating the first polar
body and adjacent cytoplasm without staining the chro-
matin. By using this "blind enucleation" method the enu-
cleation rate varies between 85% and 90% [25].
There are two approaches to put the donor nuclei into the
cytoplasts; one is direct injection of donor cells into enu-
cleated oocytes; while the second approach is to inject the
intact donor cell into the perivitelline space and subse-
quently fuse the donor cell with the recipient oocyte by
electrical pulses. With direct microinjection, the plasma
membrane and much of the cytoplasmic material of the
donor cell is not transferred. In contrast, with cell fusion,
all of the components of the donor cell (nuclear, cytoplas-
mic and plasma membrane) merge with the enucleated
oocyte.
After the donor nuclei are transferred into the enucleated
oocytes, the reconstructed embryos must be activated to
initiate subsequent development. Activation of oocytes
can be induced artificially by a variety of physical and
chemical agents. Miyoshi et al. [26] found that a delay of
3 hours between fusion and activation improved the rate
of blastocyst formation. The rate of development to the
blastocyst stage after NT has been as low as 3%. When pre-
sumptive G0 fibroblast cells were transferred to oocytes
and electrically activated, only 7% formed blastocysts.
Betthauser et al. [15] reported 4–8% blastocysts resulting
from NT that were activated by ionophore followed by 6-
dimethylaminourine. Recently, Kühholzer et al. [19]
reported almost 20% blastocysts from electrically acti-
vated oocytes. Combined thimerosal/DTT treatment of
the oocytes also could effectively activate porcine oocytes
and 42.0% of the oocytes developed to the compact
morula or blastocyst stage in vitro culture [27].
Embryo transfer
In the pig pregnancy recognition by the surrogate requires
a signal from four or more embryos around day 12 of ges-
tation [28]. To minimize any adverse effect on the in vitro
conditions on the development of NT embryos transfer to
the surrogate is generally at a very early stage. Since the NT
embryos are generally of a low quality a large number are
transferred into a single surrogate.
If not enough NT embryos are available for transfer, then
two different strategies might be employed. The first is to
co-transfer "helper embryos" as an aid to inducing and
maintaining pregnancy. These "helper embryos" maybe
parthenogenetic embryos that are capable of establishing
a pregnancy but degenerate by day 30 of gestation [6,29]
because of genomic imprinting. Alternatively the helper
embryos might be derived from a normal mating [7].
Finally, administration of estradiol, the normal signal for
maternal recognition of pregnancy, on day 12 can main-
tain the pregnancy of small litters [6,11]. Although it is
difficult to document that any of these strategies were ben-
eficial, they did not appear to hinder development.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/82
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Applications of pig cloning in genetic 
modification
Genetic modification in swine could have many agricul-
tural and medical applications. In the agricultural field,
modification of the genome could (1) alter the carcass
composition such that it is a healthier product, (2) pro-
duce pork faster or more efficiently, (3) create animals
that are resistant to specific diseases, (4) reduce the major
losses normally observed during the first month of swine
embryogenesis, and (5) create animals that are more envi-
ronmentally friendly.
In the medical field, making specific genetic modifica-
tions in the pig provides the possibility of producing
recombinant products in animals for biomedical or
nutraceutical uses and the possibility of producing mod-
els of human genetic disease for research and drug devel-
opment. Somatic NT could play important roles in genetic
modification by the following three methods.
Improving generation of transgenic pigs
Transgenic technology developed to add genes has been
widely applied to livestock species because it is technically
simple, but inefficient. Not all injected eggs will develop
into transgenic pigs, and then not all transgenic pigs will
express the transgene in the desired manner. Somatic NT
would allow more efficient generation of transgenic ani-
mals. Foreign DNA could be introduced into cell lines in
culture, and cells containing the transgene in the right
configuration could be grown up. The expression level can
be detected in individual cells, which could be deter-
mined by the addition of a reporter gene with a target
gene. The cells with high level foreign gene expression
would be selected and used as a source of nuclei for trans-
fer, ensuring that all offspring are transgenic and have
high level expression. We added a gene for the enhanced
green fluorescent protein (EGFP) to a fetal-derived cell
line by using a replication-defective retrovirus [4]. These
cells were then used as donors in a NT scheme that used
oocytes that had been matured in a defined system. The
genetically marked tissues (EGFP) from the pigs produced
from these cells will likely be very useful for basic research
where such marked cells are required. Our laboratory is
looking forward to the possibility of EGFP expressing
sperm, oocytes and embryos for our studies on fertiliza-
tion and embryo development.
Improving propagation of transgenic pigs
Nuclear transfer would speed up the expansion of a suc-
cessful transgenic line by using skin cells of the transgenic
pigs to make more clones. Ear skin fibroblasts from a
transgenic pig produced by oocyte transduction [30] and
expressing eGFP were isolated and used as donor nuclei
for NT. Four live cloned pigs were born. As in the nuclear
donor pig, all of the offspring expressed the eGFP in sim-
ilar tissues [31]. Bondioli et al. [32] (2001) produced
cloned pigs from cultured skin fibroblasts derived from an
H-transferase transgenic boar. The cells used in these stud-
ies were subjected to an extensive culture time, unsuccess-
ful transformation, freezing and thawing, and clonal
expansion from single cells prior to NT. One 90 day fetus
and two healthy piglets resulted from NT by fusion of
these fibroblasts with enucleated oocytes.
Generating Targeted Gene Alterations
The most powerful technology for genetic manipulation
in mammals – gene targeting – was developed in mice,
and depends on the ability of mammalian DNA, when
added to cells in culture, to recombine homologously
with nearly identical DNA sequences in the genome and
replace it. In mice, specific mutations can be generated in
cultured embryonic stem (ES) cells. For more than a dec-
ade, researchers have searched for ES cells from livestock,
including pigs. But although some success has been
reported, none has passed the crucial test of contributing
to the germ cells. Nuclear transfer from non-pluripotent
cell lines provides an alternative to the ES cell route for
introduction of targeted gene alterations into the germ
line. The first such example is that of knocking out a gene
that is responsible for hyperacute rejection (HAR) when
organs from swine are transferred to primates.
As described above, pig somatic NT has been established
well enough to make live cloned pigs. To generate targeted
gene alterations in pigs, creation of gene targeted somatic
cell lines becomes another critical issue to be addressed.
Generally, fibroblasts cannot proliferate indefinitely in
vitro. Senescence of primary fibroblasts in livestock is gen-
erally seen following approximately 30 populations dou-
bling ex vivo in non-clonal cultures. In pig fetal
fibroblasts, clonal isolates are generally lost at passage fol-
lowing 24–28 population doublings ex vivo. This presents
a technical hurdle as compared to mouse ES cells. How-
ever, this problem can be overcome to some extent by
using a gene trap strategy which may result in a higher tar-
geting rate [7]. To target the GGTA1 locus a long region of
homology to the GGTA1 locus was used in a vector con-
structed from the same inbred line of miniature pig from
which the fetal fibroblasts were derived, thus providing
for isogeneticity to the target locus. A stop codon and
selection cassette was inserted into exon 9, upstream of
the catalytic domain of the protein. The selection cassette
contained no promoter and was preceded by an internal
ribosome entry site. Gene trap designs of this nature have
been shown to result in relatively high targeting rates, as
the vast majority of non-targeted recombination events do
not result in transcription. Additionally, transient expres-
sion of the selection cassette cannot occur.Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/82
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In addition, transfecting the cells as early as possible after
isolation (passage 2, or about 6 population doublings)
proved to be another helpful measure to overcome the
hurdle [7]. RT-PCR can be performed on crude cell lysates
the day following transfection to quickly identify poten-
tially targeted clones. In our experiments, an absolute tar-
geting of 8 × 10-7 was obtained, which is similar to that in
mouse ES targeting (1 × 10-6) [7], producing enough cells
to be used as donor nuclei. However, it is unlikely we
could achieve two targeting events in the one primary cell
line and still maintain enough cells for NT. Rather,
removal of the second allele would be accomplished by
breeding or producing a cloned fetus, or piglet, thus pro-
viding cells which can be used for a second round of tar-
geting and NT. To produce homozygous GGTA1 knockout
piglets by natural breeding, assuming both male and
female heterozygous knockout pigs are available at the
same time and are fertile, is feasible but takes up to 12
months. However, by using a second-round knockout and
cloning strategy, we could save up to 6 months and all
cloned piglets would be GGTA1 double knockout (DKO).
One group has chosen to use second-round knockout and
cloning strategy to produce homozygous GGTA1 knock-
out piglets and successfully obtained five galactosyltrans-
ferase-deficient pigs [33]. Our group has also produced a
GGTA1 DKO by selecting cells that do not express GGTA1
originally isolated from a heterozygous knockout pig
(manuscript in preparation).
In conclusion, the techniques of NT in pigs, while devel-
oped, are not efficient. Nevertheless, the possibility of
making specific genetic modifications to pigs offers great
potential to both medicine and agriculture.
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